Biopharma

Waters CEO explains how analytical technologies can assist drug discovery

22 April 2021

Udit Batra, CEO of Waters, is known as a listener, learner and gatherer of facts. He talks to Lu Rahman about Waters’ collaboration with pharma and biopharma companies to accelerate vaccine and therapy development as well as the company’s new data analysis technology. LR: We know that the last year has been all about Covid-19, […]

From siloed to streamlined: Pharmaceutical data management is changing

14 April 2021

Claire Hill, Head of Strategic Marketing at IDBS, explores ways in which the pharmaceutical sector can reap the benefits of an increasingly digital world. The Covid-19 pandemic pushed the process of drug development into the spotlight in a new way. The challenge for biopharmaceutical companies—to create, test, and manufacture a vaccine in months rather than […]

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

11 February 2021

The Cell and Gene Therapy Catapult (CGT Catapult), an independent centre for advancing the UK’s cell and gene therapy industry, and Rentschler Biopharma, a global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, have announced that Rentschler Biopharma will establish its manufacturing capability in Advanced Therapy Medicinal Products (ATMPs), including Adeno-Associated Virus (AAV) Vectors for […]

Thermo Fisher Scientific extends collaboration to advance biopharma discovery

6 November 2020

Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody centre of excellence within the international pharmaceutical company, Servier, have extended a collaboration to deliver innovative characterisation and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development. Since the collaboration was established in 2018, Symphogen has […]

Bristol Myers Squibb licences IONTAS’ mammalian display technology

13 October 2020

IONTAS, a biotechnology company focused on antibody discovery technology development, has entered into a licensing agreement with Bristol Myers Squibb regarding its proprietary mammalian display. Under the terms of this agreement, IONTAS will receive an upfront payment for accessing the technology platform and will work with Bristol Myers Squibb in establishing the platform within its […]

Sitting down with…Biorelate

28 September 2020

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insight and innovation in drug discovery. Lu Rahman spoke to him about his vision for the business, how COVID-19 has affected the landscape and the technology behind his drug discovery success. Biorelate was founded in 2014 from scientific […]